DK49987A - Fremgangsmaade til behandling af infertilitet og middel til anvendelse ved fremgangsmaaden - Google Patents

Fremgangsmaade til behandling af infertilitet og middel til anvendelse ved fremgangsmaaden

Info

Publication number
DK49987A
DK49987A DK049987A DK49987A DK49987A DK 49987 A DK49987 A DK 49987A DK 049987 A DK049987 A DK 049987A DK 49987 A DK49987 A DK 49987A DK 49987 A DK49987 A DK 49987A
Authority
DK
Denmark
Prior art keywords
procedure
treating infertility
gonadotrophins
growth hormone
infertility
Prior art date
Application number
DK049987A
Other languages
English (en)
Other versions
DK49987D0 (da
Inventor
Howard S Jacobs
Original Assignee
Nordisk Gentofte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8094259&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK49987(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nordisk Gentofte filed Critical Nordisk Gentofte
Priority to DK049987A priority Critical patent/DK49987A/da
Publication of DK49987D0 publication Critical patent/DK49987D0/da
Priority to DE3872614T priority patent/DE3872614T3/de
Priority to AU12902/88A priority patent/AU611130B2/en
Priority to AT88901571T priority patent/ATE77961T1/de
Priority to PCT/DK1988/000012 priority patent/WO1988005662A1/en
Priority to EP88901571A priority patent/EP0300021B2/en
Priority to JP63501636A priority patent/JPH0672104B2/ja
Publication of DK49987A publication Critical patent/DK49987A/da
Priority to DK543988A priority patent/DK158542C/da
Priority to US07/488,490 priority patent/US5063204A/en
Priority to US08/328,970 priority patent/US5538948A/en
Priority to US08/430,513 priority patent/US5610138A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Massaging Devices (AREA)
  • Fuel Cell (AREA)
  • External Artificial Organs (AREA)
DK049987A 1987-01-30 1987-01-30 Fremgangsmaade til behandling af infertilitet og middel til anvendelse ved fremgangsmaaden DK49987A (da)

Priority Applications (11)

Application Number Priority Date Filing Date Title
DK049987A DK49987A (da) 1987-01-30 1987-01-30 Fremgangsmaade til behandling af infertilitet og middel til anvendelse ved fremgangsmaaden
JP63501636A JPH0672104B2 (ja) 1987-01-30 1988-01-29 不妊症の治療方法および該方法に使用するための試薬
EP88901571A EP0300021B2 (en) 1987-01-30 1988-01-29 A process for treating infertility and an agent for use in the process
AT88901571T ATE77961T1 (de) 1987-01-30 1988-01-29 Verfahren zur behandlung der unfruchtbarkeit und mittel zur verwendung dabei.
AU12902/88A AU611130B2 (en) 1987-01-30 1988-01-29 A process for treating infertility and an agent for use in the process
DE3872614T DE3872614T3 (de) 1987-01-30 1988-01-29 Verfahren zur behandlung der unfruchtbarkeit und mittel zur verwendung dabei.
PCT/DK1988/000012 WO1988005662A1 (en) 1987-01-30 1988-01-29 A process for treating infertility and an agent for use in the process
DK543988A DK158542C (da) 1987-01-30 1988-09-29 Middel til behandling af infertilitet hos hoejere pattedyr eller mennesker
US07/488,490 US5063204A (en) 1987-01-30 1990-03-02 Process for treating infertility
US08/328,970 US5538948A (en) 1987-01-30 1994-10-24 Method for treating infertility comprising administering GnRH analog, gonadotrophins, and growth hormone
US08/430,513 US5610138A (en) 1987-01-30 1995-04-27 Process for treating infertility and an agent for use in the process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK049987A DK49987A (da) 1987-01-30 1987-01-30 Fremgangsmaade til behandling af infertilitet og middel til anvendelse ved fremgangsmaaden

Publications (2)

Publication Number Publication Date
DK49987D0 DK49987D0 (da) 1987-01-30
DK49987A true DK49987A (da) 1988-07-31

Family

ID=8094259

Family Applications (2)

Application Number Title Priority Date Filing Date
DK049987A DK49987A (da) 1987-01-30 1987-01-30 Fremgangsmaade til behandling af infertilitet og middel til anvendelse ved fremgangsmaaden
DK543988A DK158542C (da) 1987-01-30 1988-09-29 Middel til behandling af infertilitet hos hoejere pattedyr eller mennesker

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK543988A DK158542C (da) 1987-01-30 1988-09-29 Middel til behandling af infertilitet hos hoejere pattedyr eller mennesker

Country Status (8)

Country Link
US (2) US5063204A (da)
EP (1) EP0300021B2 (da)
JP (1) JPH0672104B2 (da)
AT (1) ATE77961T1 (da)
AU (1) AU611130B2 (da)
DE (1) DE3872614T3 (da)
DK (2) DK49987A (da)
WO (1) WO1988005662A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK49987A (da) * 1987-01-30 1988-07-31 Nordisk Gentofte Fremgangsmaade til behandling af infertilitet og middel til anvendelse ved fremgangsmaaden
US5538948A (en) * 1987-01-30 1996-07-23 Novo Nordisk A/S Method for treating infertility comprising administering GnRH analog, gonadotrophins, and growth hormone
DK272789D0 (da) * 1989-06-02 1989-06-02 Novo Nordisk As Fremgangsmaade og praeparat til behandling af infertilitet
DK372589D0 (da) * 1989-07-28 1989-07-28 Novo Nordisk As Protein
DE4305225A1 (de) * 1993-02-19 1994-08-25 Asta Medica Ag Neues Herstellverfahren für Cetrorelix Lyophilisat
AU5065098A (en) * 1996-11-15 1998-06-10 University Of Ottawa Modulators of ovarial apoptosis related to iap
US6300311B1 (en) 1998-04-14 2001-10-09 Texas Tech University Regulation of vertebrate ovarian maturation and function using growth factors
EP1176976B2 (en) * 1999-05-07 2015-10-21 Laboratoires Serono SA Use of lh administered in mid- or late-follicular phase for the treatment of anovulatory women
EP1149583A3 (en) * 2000-04-13 2001-11-14 Pfizer Products Inc. Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues
EP1610803B8 (en) * 2003-03-04 2011-09-14 AspenBio Pharma, Inc. LH for use in maintaining one or more pregnancies by inducing accessory corpus luteum formation.
JP2008515818A (ja) * 2004-10-07 2008-05-15 ステム セル セラピューティクス コーポレイション 妊娠に関連する化合物の投与による多能性幹細胞の増殖の刺激
TWI532495B (zh) 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
CN103619358B (zh) 2011-03-31 2017-02-15 辉凌公司 药物制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0203555A3 (de) * 1985-05-31 1987-11-25 Bissendorf Peptide GmbH Mittel zur Funktionsdiagnose der Hypophyse und zur Therapie von Störungen der Hypophysenfunktionen
US4973577A (en) * 1986-04-04 1990-11-27 The Salk Institute For Biological Studies FSH-releasing peptides
DK49987A (da) * 1987-01-30 1988-07-31 Nordisk Gentofte Fremgangsmaade til behandling af infertilitet og middel til anvendelse ved fremgangsmaaden

Also Published As

Publication number Publication date
ATE77961T1 (de) 1992-07-15
DE3872614T2 (de) 1992-12-17
DE3872614T3 (de) 2002-12-05
DK158542C (da) 1990-11-05
US5610138A (en) 1997-03-11
JPH01502665A (ja) 1989-09-14
EP0300021A1 (en) 1989-01-25
AU1290288A (en) 1988-08-24
DK49987D0 (da) 1987-01-30
JPH0672104B2 (ja) 1994-09-14
EP0300021B1 (en) 1992-07-08
EP0300021B2 (en) 2002-05-29
DK158542B (da) 1990-06-05
DK543988A (da) 1988-09-30
AU611130B2 (en) 1991-06-06
DE3872614D1 (de) 1992-08-13
US5063204A (en) 1991-11-05
WO1988005662A1 (en) 1988-08-11
DK543988D0 (da) 1988-09-29

Similar Documents

Publication Publication Date Title
DK49987A (da) Fremgangsmaade til behandling af infertilitet og middel til anvendelse ved fremgangsmaaden
MY113490A (en) Modified anti-icam-1 antibodies and their use in the treatment of inflammation
DK442688D0 (da) Fremgangsmaade og praeparat til behandling af non-ige-medierede lidelser
NO873699L (no) Polypeptid som er egnet til dempning, behandling og diagnostisering av autoimmune lidelser saasom leddbetennelser.
GB2100601B (en) An aromatase-inhibitor for use in a method of prophylaxis and/or of treatment by therapy of prostatic hyperplasia, and pharmaceutical preparations suitable for such a use.
BR9105783A (pt) Polipeptidio,processo para o tratamento em vidro de neuronios e composicoes celular e farmaceutica
DK526689A (da) Fremgangsmaade til behandling og forebyggelse af pneumocystis carinii pheumonia og andre sygdomme, og forbindelser og formuleringer til anvendelse ved denne fremgangsmaade
DE68917433D1 (de) Verfahren zur behandlung von asbest sowie asbestbehandlungsmittel.
DK0474787T3 (da) Fremgangsmåde til behandling af infertilitet og middel til anvendelse ved fremgangsmåden
NO890643D0 (no) Fremgangsmaate ved behandling av avluft og avgass.
NO894008L (no) Trekonserveringsmiddel og fremgangsmaate for behandling avtre med samme.
GB2271509B (en) Antivenom immunesera
NO982582L (no) Fremgangsmaate for behandling av smerte
NO883329L (no) Anordning og fremgangsmaate for reduksjon av kjelestensdannelse i tremasse-prosesser.
NO881414L (no) Fremgangsmaate for behandling av spillvann og annet urent vann.
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
DK0484429T3 (da) Fremgangsmåde til behandling af infertilitet eller sub-fertilitet hos voksne mænd, og brugen af præparater til fremgangsmåden
IE872567L (en) Treatment of infertility
UA9522A (uk) Спосіб лікування аутоімунного тиреоідиту
UA19109A (uk) Спосіб посилеhhя протилейкозhої активhості циклофосфаhу
NO900044L (no) Hemorroidale, andre blandinger og metoder for behandling.
PT88090A (pt) Processo para o tratamento da infertilidade e para a preparacao de uma composicao utilizada nesse tratamento
TH14586A (th) การบำบัดรักษาการเป็นหมัน และเพิ่มความสามารถในการผลิตคิดในสัตว์เลี้ยงลูกด้วยนมตัวผู้
NO894972L (no) Polypeptidforbindelser med veksthormon-frigjoerende aktivitet.
MY109685A (en) Method for treating hepatitis b carriers with minimal disease

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment